Home > Insider Trading > Filing (0001179110-13-009373)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
815094	Abiomed Inc	ABMD	Surgical & Medical Instruments & Apparatus (3841)	042743260

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1286370	R Michael Minogue	C/O Abiomed, Inc., 22 Cherry Hill Drive Danvers MA 01923	President, Ceo, Chairman	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, $.01 Par Value	Disposition	2013-05-28	34,633	$22.18	230,156	No	4	S	Direct
Common Stock, $.01 Par	Acquisiton	2013-05-28	51,000	$0.00	281,156	No	4	A	Direct
Common Stock $.01 Par Value	Disposition	2013-05-29	24,200	$21.34	256,956	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	A	Direct
No	4	S	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (right to buy)	$9.36	2006-06-08	2015-06-08	39,383	39,383	Direct
Common Stock	Stock Option (right to buy)	$13.57	2007-06-01	2016-06-01	260,000	260,000	Direct
Common Stock	Stock Option (right to buy)	$11.27	2008-05-30	2017-05-30	85,000	85,000	Direct
Common Stock	Stock Option (right to buy)	$13.80	2009-05-23	2018-05-23	43,333	43,333	Direct
Common Stock	Stock Option (right to buy)	$18.63	2009-06-15	2018-08-13	93,750	93,750	Direct
Common Stock	Stock Option (right to buy)	$5.86	2010-05-28	2019-05-28	37,000	109,800	Direct
Common Stock	Stock Option (right to buy)	$5.86	2010-03-31	2019-05-28	130,500	130,500	Direct
Common Stock	Stock Option (right to buy)	$10.03	2011-06-03	2020-06-03	105,000	105,000	Direct
Common Stock	Stock Option (Right to Buy)	$22.44	2013-05-22	2022-05-22	100,000	100,000	Direct
Common Stock	Stock Option (Right to Buy)	$23.15	2014-05-14	2024-05-14	85,000	85,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2015-06-08	39,383	39,383	Direct
2016-06-01	260,000	260,000	Direct
2017-05-30	85,000	85,000	Direct
2018-05-23	43,333	43,333	Direct
2018-08-13	93,750	93,750	Direct
2019-05-28	37,000	109,800	Direct
2019-05-28	130,500	130,500	Direct
2020-06-03	105,000	105,000	Direct
2022-05-22	100,000	100,000	Direct
2024-05-14	85,000	85,000	Direct

Footnotes

Grant to reporting person of option to buy shares of Common Stock under the ABIOMED, Inc. 2000 Stock Incentive Plan.
These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
These options become exercisable based on the achievement of certain performance milestones.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $21.9800 and $22.4200. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
Sale of common stock pursuant to reporting owner's 10b5-1 plan.
This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $21.0000 and $21.9800. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
These restricted stock units will vest in 50% increments, the first 50% on May 22, 2014 and the remaining 50% on May 22, 2015.